Corpus overview


Overview

MeSH Disease

HGNC Genes

There are no HGNC terms in the subcorpus


SARS-CoV-2 proteins

There are no SARS-CoV-2 protein terms in the subcorpus


Filter

Genes
Diseases
SARS-CoV-2 Proteins
    displaying 1 - 1 records in total 1
    records per page




    The Impact of Coronavirus Disease 2019 MESHD Pandemic on People with Diabetes in Indonesia: A Cross Sectional National Scale Web-Survey

    Authors: Ida Ayu Kshanti; Marina Epriliawati; Md Ikhsan Mokoagow; Jerry Nasarudin; Nadya Magfira

    doi:10.1101/2020.12.01.20241588 Date: 2020-12-03 Source: medRxiv

    Background As the country with the 7th largest number of People with Diabetes MESHD ( PWD MESHD) in the world, the COVID-19 MESHD COVID-19 MESHD pandemic, and the Large Social Scale Restriction (LSSR) policy taken by the Indonesian government to reduce the number of COVID-19 MESHD transmissions is estimated to interfere diabetes MESHD management and will increase the incidence of diabetes complications MESHD. This study aims to determine the difficulties of diabetes MESHD management and its impact on diabetes MESHD morbidity during the COVID-19 pandemic MESHD in Indonesia. Methods This study is a cross-sectional study using a national scale web survey. This research was conducted in Indonesia enrolling 1,124 PWD MESHD aged 18 years or older. Diabetes complications MESHD are defined as any incidence of hypoglycaemia, or Diabetic Foot Ulcer MESHD ( DFU MESHD), or hospital admission experienced by PWD MESHD in Indonesia during the COVID-19 pandemic MESHD. The correlation between diabetes MESHD management difficulties and diabetes MESHD-related complications was measured using a modified cox regression test. Results Diabetes MESHD management difficulties were experienced by 69.8% of PWD in Indonesia MESHD. The difficulties include attending diabetes MESHD consultation 30.1%, access to diabetes MESHD medication 12.4%, checking blood sugar levels 9.5%, controlling diet 23.8%, and performing regular exercise 36.5%. Diabetes MESHD-related complications occurred in 24.6% of subjects. Those who had diabetes MESHD management difficulties during the COVID-19 pandemic MESHD are prone to have diabetes MESHD complications by 1.4 times greater (PR: 1.41, 95% CI: 1.09-1.83) than those who did not. Conclusion The COVID-19 pandemic MESHD and LSSR have a substantial impact on diabetes MESHD management and indirectly increased diabetes morbidity in Indonesia MESHD.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
HGNC Genes
SARS-CoV-2 Proteins


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.